SPARC and gastric cancer: The survival curves showed that the overall survival rate of macrophage-derived SPARC patients with low expression of gastric cancer was lower than that of patients with high expression of SPARC, but the difference was not statistically significant (χ2=3.106, P = 0.078, Fig. 1D).